The current draft of the Build Back Better Act includes language to amend the Orphan Drug Tax Credit (ODTC) in ways that would severely undermine efforts to ensure more patients have access to a safe and effective drug for their rare condition.
Please reach out to your legislators today and ask them to remove the proposed changes to the Orphan Drug Tax Credit from the Build Back Better Act.